What is Mainz Biomed N.V. Ordinary Shares's Market Cap?

Mainz Biomed N.V. Ordinary Shares's Market Cap is $118.5M, based on as-reported figures from SEC (XBRL) filings.

What is Mainz Biomed N.V. Ordinary Shares's Enterprise Value?

Mainz Biomed N.V. Ordinary Shares's Enterprise Value is $113.8M, based on as-reported figures from SEC (XBRL) filings.

What is Mainz Biomed N.V. Ordinary Shares's Price / Sales?

Mainz Biomed N.V. Ordinary Shares's Price / Sales is 220.7×, based on as-reported figures from SEC (XBRL) filings.

What is Mainz Biomed N.V. Ordinary Shares's EV / Revenue?

Mainz Biomed N.V. Ordinary Shares's EV / Revenue is 212.0×, based on as-reported figures from SEC (XBRL) filings.

What is Mainz Biomed N.V. Ordinary Shares's EV / EBITDA?

Mainz Biomed N.V. Ordinary Shares's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.

What is Mainz Biomed N.V. Ordinary Shares's Revenue (TTM)?

Mainz Biomed N.V. Ordinary Shares's Revenue (TTM) is $537.1K, based on as-reported figures from SEC (XBRL) filings.

What is Mainz Biomed N.V. Ordinary Shares's Net Income (TTM)?

Mainz Biomed N.V. Ordinary Shares's Net Income (TTM) is -$16.3M, based on as-reported figures from SEC (XBRL) filings.

What is Mainz Biomed N.V. Ordinary Shares's EBITDA?

Mainz Biomed N.V. Ordinary Shares's EBITDA is -$15.3M, based on as-reported figures from SEC (XBRL) filings.

What is Mainz Biomed N.V. Ordinary Shares's Diluted EPS (TTM)?

Mainz Biomed N.V. Ordinary Shares's Diluted EPS (TTM) is -0.19, based on as-reported figures from SEC (XBRL) filings.

What is Mainz Biomed N.V. Ordinary Shares's EBITDA Margin?

Mainz Biomed N.V. Ordinary Shares's EBITDA Margin is -2856.9%, based on as-reported figures from SEC (XBRL) filings.

Mainz Biomed N.V. Ordinary Shares (QUCY) Financial Statements

Mainz Biomed N.V. Ordinary Shares

SIC 2834 · PHARMACEUTICAL PREPARATIONS

FIGI AK-C4F4FC36D2

XNAS · usd

1.41▼ 0.01 (-0.70%)

As of 2026-09-09

Valuation

Market Cap

Enterprise Value

Trailing P/E—

Price / Sales

EV / Revenue

EV / EBITDA

Financial Highlights

Revenue (TTM)

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin

Net Debt

Trading Information

Previous Close1.42

Day's Range1.41 – 1.56

52-Week Range0.30 – 4.93

Volume1.3M

Avg Volume864.8K

Share Statistics

Shares Outstanding

Employees13

ExchangeXNAS

Listed2021-11-05

Share count as of August 13, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Mainz Biomed N.V. Ordinary Shares (QUCY)

What is Mainz Biomed N.V. Ordinary Shares's Market Cap?: Mainz Biomed N.V. Ordinary Shares's Market Cap is $118.5M, based on as-reported figures from SEC (XBRL) filings.
What is Mainz Biomed N.V. Ordinary Shares's Enterprise Value?: Mainz Biomed N.V. Ordinary Shares's Enterprise Value is $113.8M, based on as-reported figures from SEC (XBRL) filings.
What is Mainz Biomed N.V. Ordinary Shares's Price / Sales?: Mainz Biomed N.V. Ordinary Shares's Price / Sales is 220.7×, based on as-reported figures from SEC (XBRL) filings.
What is Mainz Biomed N.V. Ordinary Shares's EV / Revenue?: Mainz Biomed N.V. Ordinary Shares's EV / Revenue is 212.0×, based on as-reported figures from SEC (XBRL) filings.
What is Mainz Biomed N.V. Ordinary Shares's EV / EBITDA?: Mainz Biomed N.V. Ordinary Shares's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Mainz Biomed N.V. Ordinary Shares's Revenue (TTM)?: Mainz Biomed N.V. Ordinary Shares's Revenue (TTM) is $537.1K, based on as-reported figures from SEC (XBRL) filings.
What is Mainz Biomed N.V. Ordinary Shares's Net Income (TTM)?: Mainz Biomed N.V. Ordinary Shares's Net Income (TTM) is -$16.3M, based on as-reported figures from SEC (XBRL) filings.
What is Mainz Biomed N.V. Ordinary Shares's EBITDA?: Mainz Biomed N.V. Ordinary Shares's EBITDA is -$15.3M, based on as-reported figures from SEC (XBRL) filings.
What is Mainz Biomed N.V. Ordinary Shares's Diluted EPS (TTM)?: Mainz Biomed N.V. Ordinary Shares's Diluted EPS (TTM) is -0.19, based on as-reported figures from SEC (XBRL) filings.
What is Mainz Biomed N.V. Ordinary Shares's EBITDA Margin?: Mainz Biomed N.V. Ordinary Shares's EBITDA Margin is -2856.9%, based on as-reported figures from SEC (XBRL) filings.